Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Flynn

Showing results (511-520 of 644) with videos related to

Pageof 65
Sort By:
Physics in Medicine and Biology|November 16, 2002
Spatial accuracy of 3D reconstructed radioluminographs of serial tissue sections and resultant absorbed dose estimatesI A Petrie, A A Flynn, R B Pedley, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|July 16, 2015
Effect of Ramipril on Urinary Protein Excretion in Maintenance Renal Transplant Patients Converted to SirolimusD A Mandelbrot, J Alberú, A Barama, et al.
The Journal of Pharmacology and Experimental Therapeutics|June 1, 1995
Pharmacological characterization of PD 156707, an orally active ETA receptor antagonistE E Reynolds, J A Keiser, S J Haleen, et al.
Cancer Chemotherapy and Pharmacology|August 19, 2000
Recombinant anti-carcinoembryonic antigen antibodies for targeting cancerK A Chester, A Mayer, J Bhatia, et al.
RNA (New York, N.Y.)|November 21, 2014
Dissecting noncoding and pathogen RNA-protein interactomesRyan A Flynn, Lance Martin, Robert C Spitale, et al.
Journal of Cardiovascular Pharmacology|January 1, 1995
Structure-activity relationships of a novel series of orally active nonpeptide ETA and ETA/B endothelin receptor-selective antagonistsA M Doherty, W C Patt, J Repine, et al.
Nature Communications|August 1, 2025
Development and application of GlycanDIA workflow for glycomic analysisYixuan Xie, Xingyu Liu, Li Yi, et al.
Value in Health Regional Issues|April 29, 2018
The Health Technology Assessment Environment in Mainland China, Japan, South Korea, and Taiwan-Implications for the Evaluation of Diabetes Mellitus TherapiesTessa Kennedy-Martin, Beth D Mitchell, Kristina S Boye, et al.
Journal of Cardiovascular Pharmacology|January 1, 1993
In vitro and in vivo studies with a series of hexapeptide endothelin antagonistsA M Doherty, W L Cody, J X He, et al.
Journal of Medicinal Chemistry|July 21, 1995
Structure-activity relationships of the potent combined endothelin-A/endothelin-B receptor antagonist Ac-DDip16-Leu-Asp-Ile-Ile-Trp21: development of endothelin-B receptor selective antagonistsW L Cody, J X He, P L DePue, et al.
Pageof 65

Showing results (511-520 of 644) with videos related to

Sort By:
Pageof 65
Physics in Medicine and Biology|November 16, 2002
Spatial accuracy of 3D reconstructed radioluminographs of serial tissue sections and resultant absorbed dose estimatesI A Petrie, A A Flynn, R B Pedley, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|July 16, 2015
Effect of Ramipril on Urinary Protein Excretion in Maintenance Renal Transplant Patients Converted to SirolimusD A Mandelbrot, J Alberú, A Barama, et al.
The Journal of Pharmacology and Experimental Therapeutics|June 1, 1995
Pharmacological characterization of PD 156707, an orally active ETA receptor antagonistE E Reynolds, J A Keiser, S J Haleen, et al.
Cancer Chemotherapy and Pharmacology|August 19, 2000
Recombinant anti-carcinoembryonic antigen antibodies for targeting cancerK A Chester, A Mayer, J Bhatia, et al.
RNA (New York, N.Y.)|November 21, 2014
Dissecting noncoding and pathogen RNA-protein interactomesRyan A Flynn, Lance Martin, Robert C Spitale, et al.
Journal of Cardiovascular Pharmacology|January 1, 1995
Structure-activity relationships of a novel series of orally active nonpeptide ETA and ETA/B endothelin receptor-selective antagonistsA M Doherty, W C Patt, J Repine, et al.
Nature Communications|August 1, 2025
Development and application of GlycanDIA workflow for glycomic analysisYixuan Xie, Xingyu Liu, Li Yi, et al.
Value in Health Regional Issues|April 29, 2018
The Health Technology Assessment Environment in Mainland China, Japan, South Korea, and Taiwan-Implications for the Evaluation of Diabetes Mellitus TherapiesTessa Kennedy-Martin, Beth D Mitchell, Kristina S Boye, et al.
Journal of Cardiovascular Pharmacology|January 1, 1993
In vitro and in vivo studies with a series of hexapeptide endothelin antagonistsA M Doherty, W L Cody, J X He, et al.
Journal of Medicinal Chemistry|July 21, 1995
Structure-activity relationships of the potent combined endothelin-A/endothelin-B receptor antagonist Ac-DDip16-Leu-Asp-Ile-Ile-Trp21: development of endothelin-B receptor selective antagonistsW L Cody, J X He, P L DePue, et al.
Pageof 65